HPSP director presents Thailand’s status of particle therapy at PTCOG-AO 2022
Back to NewsHPSP director presents Thailand’s status of particle therapy at PTCOG-AO 2022Dr.
HPSP radiation oncologist shares an early ASEAN experience at AROICON 2022
Back to NewsHPSP radiation oncologist shares an early ASEAN experience at AROICON 2022Dr.
Hypofractionated and proton radiotherapy in breast cancer
Prof.Chawalit Lertbutsayanukul
View FullscreenSkip to PDF content
Normal tissue complication probability (NTCP) model-based approach for patient selection for proton therapy
Dr.Anussara Prayongrat
View FullscreenSkip to PDF content
Proton therapy in hepatocellular carcinoma
Dr. Napapat Amornwichet
View FullscreenSkip to PDF content
Proton therapy in non-small cell lung cancer (article in Thai)
Asst.Prof. Danita Kannarunimit
View FullscreenSkip to PDF content